NSUN2‐mediated m5C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression

BACKGROUND: C modification in carcinogenesis remains to be fully addressed. METHODS: C-PFAS oncogenic cascade. RESULTS: C modification of PFAS, increasing its expression by enhancing its RNA stability. CONCLUSIONS: C reprogramming therapeutic strategy may be a novel and efficient anti-tumour therapy approach.